Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Eshelman Fredric N
Relationship:   10% Owner
City:   Wilmington
State:   NC
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   8,151,654    

Indirect Shares

  3,933,809      
Direct Value   $86,486,376    

Indirect Value

  $13,868,647      
Total Shares   12,085,463      
Total Value   $100,355,023      


Bausch Health Companies Inc
 $240,894 G1 Therapeutics Inc
 $827,500 Eyenovia Inc
 $920,464 Liquidia Technologies Inc
 $84,497,517 Bausch Health Companies Inc
 $240,894 G1 Therapeutics Inc
 $827,500 Eyenovia Inc
 $920,464 Liquidia Technologies Inc
 $84,497,517
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    7   
    3    

     Stock price went up :

    0   
    0    
     Stock price went down :
    7   
    3    
   
     Gain/Loss Ratio :
   -7.0   
   -3.0   
     Percentage Gain/Loss :
   -45.7%
 -43.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmaceutical Product Developme... PPDI Executive Chairman, Di... 2011-12-05 0 2011-12-05 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director, 10% Owner 2014-07-02 0 2014-07-02 0    Premium*  
            Bausch Health Companies Inc BHC Director 2017-05-05 38,298 2016-03-11 0    Premium*  
            G1 Therapeutics Inc GTHX Director, 10% Owner 2017-11-13 250,000 2017-11-13 3,439,151    Premium*  
            Eyenovia Inc EYEN Director 2020-09-11 1,292,787 2020-09-11 319,085    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2020-11-25 6,570,569 2020-11-25 175,573    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-01 4 S $35.03 $2,229,681 D/D (63,433) 8,768,194 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-01 4 S $34.63 $663,142 D/D (19,000) 8,831,627 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-14 4 S $33.79 $305,160 D/D (9,000) 8,683,960 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-14 4 S $33.48 $2,497,943 D/D (74,334) 8,692,960 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-01 4 S $36.39 $2,273,094 D/D (61,792) 8,622,168 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-01 4 S $37.27 $7,454 D/D (200) 8,600,627 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-01 4 S $36.91 $789,374 D/D (21,341) 8,600,827 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-18 4 S $36.86 $1,028,407 D/D (27,852) 8,517,293 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-18 4 S $36.56 $2,036,971 D/D (55,382) 8,545,145 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-19 4 S $36.58 $3,658 D/D (100) 8,600,227 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-02 4 S $38.01 $1,831,020 D/D (47,900) 8,469,393 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-02 4 S $38.33 $1,361,527 D/D (35,433) 8,433,960 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-16 4 S $38.37 $824,675 D/D (21,400) 8,396,126 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-16 4 S $38.69 $1,611,552 D/D (41,496) 8,354,630 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-16 4 S $37.99 $627,749 D/D (16,434) 8,417,526 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-16 4 S $38.99 $156,255 D/D (4,004) 8,350,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-12-05 4 A $0.00 $0 D/D 100,000 8,450,636 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-12-11 4 GD $0.00 $0 D/D 190,000 8,260,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-12-13 4 GD $0.00 $0 D/D 6,000 8,254,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-12-27 4 D $0.00 $0 D/D (100,000) 8,154,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-05-19 4 S $42.83 $1,720,793 D/D (40,000) 8,114,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-05-20 4 S $42.63 $2,785,830 D/D (65,220) 8,018,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-05-20 4 S $42.52 $1,310,091 D/D (30,780) 8,083,846 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-05-21 4 S $43.53 $609,718 D/D (14,000) 8,004,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-08-06 4 GD $0.00 $0 D/D 39,000 7,965,626 0 -

  148  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed